http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5759816-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ac661be0b9a884290451af2b1432123 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
| filingDate | 1995-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4cc06bbfd55334bfa7abe7d7d068c94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_766002c7265282bc8a9fcfbb3582bfd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ea9906a38fdcfd72d7539590e4aaf13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc4bfee378dc984501afddc86287933 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730a7ffd730f599fb1b5e6f4b5793fe3 |
| publicationDate | 1998-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5759816-A |
| titleOfInvention | Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods |
| abstract | An improved vector upon introduction into a suitable host containing the thermolabile repressor CI renders the host capable of effecting expression of a desired gene. The vector is a double-stranded DNA molecule which includes in 5' to 3' order the following: the promoter and operator PLOL from lambda bacteriophage; the N utilization site; a first restriction enzyme site permitting replacement of the ribosomal binding site which follows thereafter; a ribosomal binding site; an ATG initiation codon or DNA which is converted into an ATG initiation codon upon insertion of the desired gene into the vector; a second restriction enzyme site for inserting the gene in phase with the ATG codon; a T1T2 rRNA transcription termination sequence; an origin of replication and a gene associated with a selectable or identifiable phenotypic trait manifested when the vector is present in the host. The distance between the 3' end of the PLOL promoter and operator sequence and the 5' end of the N utilization site is less than about 80 base pairs and the distance between the 3' end of the N utilization site and the 5' end of the ribosomal binding site is less than about 300 base pairs. Plasmids have been constructed from the vectors and used to produce bovine, chicken and porcine growth hormones, human apolipoprotein E and human superoxide dismutase. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03054014-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003113808-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03054014-A3 |
| priorityDate | 1984-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.